MedTrace Logo

Investigation of the Effects of Short Foot Exercise and Mobilization in Young Adults With Pes Planus

NCT07107763 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2025-12-18

No results posted yet for this study

Summary

Pes Planus (PP) is a foot deformity characterized by a lower-than-normal medial longitudinal arch. Individuals diagnosed with PP experience various challenges in daily life. Among these challenges are limitations in balance and movement skills. To reduce the effects of PP, several treatment approaches are preferred. These interventions are generally categorized into surgical and conventional treatments. Among conservative approaches, the short foot exercise is one of the most fundamental and commonly used methods. This exercise aims to strengthen the intrinsic muscles of the foot to support the arch. In addition to the short foot exercise, other exercises such as towel scrunching and toe spreading are also used in the management of PP. However, when looking at the treatment options for PP, studies examining the use and effects of joint mobilization are limited. The present study aims to investigate the effects of subtalar joint mobilization, short foot exercises, and the combined application of these interventions in individuals with PP. This approach is based on findings that subtalar joint mobilization has positive effects on balance in individuals with balance impairments.

Conditions

  • Pes Planus

Interventions

OTHER

short foot exercise

The short foot exercise group will receive stretching exercises and short foot exercises, administered three sessions per week for a duration of six weeks.

OTHER

Mobilization

The mobilization group will undergo a program consisting of 3 sessions per week for a duration of 6 weeks. The sessions will begin with stretching exercises, followed by subtalar joint mobilization.

COMBINATION_PRODUCT

Short foot exercise and mobilization

The combined intervention used in this group will include both of the approaches applied in the other two groups.

Sponsors & Collaborators

  • Kirsehir Ahi Evran Universitesi

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-26
Primary Completion
2025-12-17
Completion
2025-12-17

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07107763 on ClinicalTrials.gov